Oncogenic miR-744 promotes prostate cancer growth through direct targeting of LKB1
Sign Up to like & getrecommendations! Published in 2019 at "Oncology Letters"
DOI: 10.3892/ol.2018.9822
Abstract: Prostate cancer (PCa) is one of the most common malignancies worldwide, and with a limited number of treatments for this type of cancer, its incidence is rapidly increasing. Patients presenting with PCa are likely to… read more here.
Keywords: cancer; targeting lkb1; cell; mir 744 ... See more keywords